(Medical Xpress)—A small molecule developed at Yale University to limit damage done by ischemia – restricted blood flow – during heart attacks or surgery has been shown to reduce by 40 percent the amount of heart muscle damaged by myocardial infarction in animal studies by University at Buffalo pharmacologists.
↧